VTYX - VENTYX BIOSCIENCES INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Ventyx Biosciences Inc. (NASDAQ: VTYX) | Benzinga
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX)?
- Did you purchase your shares pursuant and/or traceable to the Company's October 21, 2021 IPO, or between October 21, 2021 and November 6, 2023, inclusive?
- Did you lose money in your investment in Ventyx Biosciences, Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired: (a) Ventyx Biosciences, Inc. ("Ventyx" or the "Company") common stock pursuant and/or traceable to the offering documents issued in connection with the Company's initial public offering conducted on or about October 21, 2021 (the "IPO" or "Offering"); and/or (b) Ventyx securities between October 21, 2021 and November 6, 2023, both dates inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the Southern District of California and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 (the "Complaint").
If you purchased or acquired Ventyx securities, including pursuant to the IPO, and/or would like to discuss your legal rights and options please visit Ventyx Biosciences, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
According to the Complaint, Ventyx is a ...
VTYX)>Full story available on Benzinga.com